The purpose of this article is to describe the role of MUTYH mutations in the pathogenesis of cancer and describe its emerging use in early detection, treatment decisions, and possible targeted therapies for ovarian cancer. The gene discussed is MUTYH; the disease is ovarian carcinoma.